Neidio i'r cynnwys
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Uwch
  • Principal factor analysis of p...
  • Dyfynnu hwn
  • Anfonwch hwn fel neges destun
  • E-bostio hwn
  • Argraffu
  • Allforio Cofnod
    • Allforio i RefWorks
    • Allforio i EndNoteWeb
    • Allforio i EndNote
  • Permanent link
Principal factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients.

Principal factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients.

Manylion Llyfryddiaeth
Prif Awduron: Generali, D, Fox, S, Buffa, F, Berruti, A, Brizzi, M, Allevi, G, Bonardi, S, Dogliotti, L, Bottini, A, Harris, A
Fformat: Conference item
Cyhoeddwyd: 2006
  • Daliadau
  • Disgrifiad
  • Eitemau Tebyg
  • Dangos Staff

Eitemau Tebyg

  • Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
    gan: Generali, D, et al.
    Cyhoeddwyd: (2006)
  • Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
    gan: Generali, D, et al.
    Cyhoeddwyd: (2006)
  • Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
    gan: Generali, D, et al.
    Cyhoeddwyd: (2009)
  • Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
    gan: Mele, T, et al.
    Cyhoeddwyd: (2010)
  • Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
    gan: Mele, T, et al.
    Cyhoeddwyd: (2010)

Opsiynau Chwilio

  • Hanes Chwilio
  • Chwiliad Uwch

Canfod Mwy

  • Pori'r Catalog
  • Pori yn ôl y Wyddor
  • Archwiliwch Sianeli
  • Cronfeydd y Cwrs
  • Eitemau Newydd

Angen Help?

  • Awgrymiadau Chwilio
  • Gofynnwch i Lyfrgellydd
  • Cwestiynau Cyffredin